Stay updated on Brentuximab & Nivolumab for Early Hodgkin Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Brentuximab & Nivolumab for Early Hodgkin Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Brentuximab & Nivolumab for Early Hodgkin Lymphoma Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    12 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    The page’s footer revision/version indicator was updated from v3.5.2 to v3.5.3, reflecting a site/software release rather than any modification to the clinical trial information.
    Difference
    0.0%
    Check dated 2026-04-27T07:34:50.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-20T03:00:14.000Z thumbnail image
  5. Check
    55 days ago
    Change Detected
    Summary
    Revision: v3.5.0 released, replacing the previous v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-22T05:32:14.000Z thumbnail image
  6. Check
    69 days ago
    Change Detected
    Summary
    - Page version updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-07T19:16:55.000Z thumbnail image
  7. Check
    91 days ago
    Change Detected
    Summary
    Revision updated from v3.4.1 to v3.4.2, a minor update that does not affect core content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-14T04:04:05.000Z thumbnail image
  8. Check
    98 days ago
    Change Detected
    Summary
    A new site revision label appears: Revision: v3.4.1 replaces Revision: v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-07T00:47:25.000Z thumbnail image

Stay in the know with updates to Brentuximab & Nivolumab for Early Hodgkin Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Brentuximab & Nivolumab for Early Hodgkin Lymphoma Clinical Trial page.